BrosMed Medical Co., Ltd. Announces CE Mark Approval of the Tri-Wedge PTA Scoring Balloon Dilatation Catheter

February 19th, 2020—BrosMed Medical Co., Ltd. announced CE Mark and launched its Tri-Wedge PTA Balloon Catheter. Tri-Wedge is a Percutaneous Transluminal Angioplasty (PTA) Scoring Balloon Dilatation Catheter, which ideal for Arteriovenous Fistula (AV) Shunt Scoring.

Tri-Wedge PTA Scoring Balloon Dilatation Catheter achieves accurate annular fibrous, calcified plaque location and minimal balloon slippage. This balloon with trimetallic wires can reach lesions smoothly with an uniform vertical distribution. High efficient vertical extrusion to score the plaque with concentrated dilatation stress, low pressure and high safety dilatation reduces the vessel wall injury and incidence of restenosis.

“Tri-Wedge Peripheral balloon provides excellent crossing ability, high pressure and non-compliance. It was ideally designed in the treatment of complex lesions with significant calcification and fibrosis. It is believed this unique balloon design technology will make a difference to the PTA scoring balloon market.” said by Stephen Lee, Sr. vice president of BrosMed Medical Co., Ltd. “By continuously improving our balloon performance, we support physicians solving the complex lesions cases”

For more product details and information, please contact your regional distributor and/or our direct sales force at sales@brosmed.comcs@brosmed.com or +86 769 22892018 / +31 850 140901.

 

About BrosMed Medical

BrosMed Medical is more than just a company; we are leading the medical device design and manufacturing revolution.

BrosMed Medical develops, manufactures and markets medical devices primarily used by interventional cardiologists, radiologists and vascular surgeons in angioplasty procedures and other minimal invasive devices.

We provide solutions to our customers through innovative design, effective supply chain management, world-class manufacturing, and flexible channels of distribution and through the development or acquisition of innovative technologies.

BrosMed Medical product portfolio consist of, Artimes™ PTCA, Apollo™ PTCA, Atropos™ 0.035 PTA, Minerva™ 0.018 PTA, Polux™ 0.014 PTA, Hermes™ NC 0.035 PTA, Achilles™ NC 0.018 PTA, Castor™  NC 0.014 PTA, Conger™ Hydrophilic coated wire and series of accessories. NC